CD

Colleen Davenport

Vice President Regulatory Affairs at Radius Health

Colleen Davenport has a strong background in regulatory affairs, with extensive experience in the pharmaceutical industry. Colleen is currently working as the Vice President of Regulatory Affairs at Radius Health, Inc. In this role, Colleen is responsible for managing regulatory strategies and ensuring compliance with regulations. Prior to their current position, they held various leadership roles at Bristol-Myers Squibb, AnGes Inc, and GlaxoSmithKline, where they played crucial roles in regulatory development and strategy. Additionally, Colleen worked at Accenture as an Associate Director, providing regulatory consulting and preparing global dossiers. Colleen has a proven track record in coordinating with regulatory authorities and preparing regulatory documentation. Colleen began their career at Sanofi-Aventis, where they served as the Director of Regulatory Development and played a key role in global regulatory lead for cardiovascular projects. Colleen also worked at GlaxoSmithKline as a Clinical Team Manager/Regulatory Writer and as an Investigator in the Immunology Group. Colleen's work experience demonstrates their expertise in regulatory affairs and their ability to effectively manage and oversee regulatory processes.

Colleen Davenport obtained their Bachelor of Science (BS) with Distinction in Microbiology from Penn State University from 1986 to 1990. Colleen then pursued a Doctor of Philosophy (PhD) in Immunology at UT Southwestern Medical Center from 1990 to 1995. Colleen completed a Project Management Certification at Penn State University from 1999 to 2000. Lastly, they earned their Master's degree in Regulatory Affairs from Temple University between 2002 and 2006.

Links

Previous companies

Sanofi logo
Accenture logo
Bristol-Myers Squibb logo

Timeline

  • Vice President Regulatory Affairs

    January, 2022 - present

  • Executive Director Regulatory Affairs

    November, 2020

  • Senior Director Regulatory Affairs

    September, 2018

View in org chart